MIR3153

Across TCGA pan-cancer cohorts, MIR3153 RNA differs between tumor and matched normal tissue in 13 of 18 cancer types tested, making tumor–normal expression one of MIR3153’s most consistent transcriptional readouts.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where MIR3153 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR3153 is over-expressed in tumor.

BLCA, HNSC, and COAD are the cancer types where MIR3153 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR3153 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BLCA	Male	All	+1.764	<.001	11	view →
HNSC	All	III,IV	+0.558	<.001	11	view →
COAD	All	II,III,IV	+0.918	<.001	9	view →
UCEC	All	All	+0.900	<.001	8	view →
READ	All	All	+2.171	<.001	7	view →
BRCA	All	All	+1.446	<.001	6	view →
STAD	All	II,III,IV	+1.275	<.001	6	view →
LUSC	All	All	+0.780	<.001	5	view →
KIRC	Male	All	+0.276	.001	5	view →
KICH	All	All	+0.585	.006	4	view →
ESCA	All	All	+1.376	<.001	3	view →
CHOL	All	All	+1.026	.012	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 13 lineages.

MIR3153–BLCA

Open the BLCA breakdown →